WANG LAI (Global Head of R&D) sold 756.00 shares of BEONE MEDICINES LTD. on the open market
Open‑market sale worth $197.3K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/15/2026ACC: 0001852291-26-000005
Officer· Global Head of R&D
Since Apr 2021
+347.64K
Net shares
Net buyer
$197.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
348.40K acquired · 756.00 disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+118.63K
Price / share
—
Trade value
—
% of position
7.5%
6/11/2026
1.59M→1.71M
American Depositary Shares
Direct
Shares
−756.00
Price / share
$261.00
Trade value
$197.32K
% of position
New position
6/11/2026
756.00→0.00
Total
Net shares
+117.87K
Net value
-$197.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 6/11/2026 | A · Award | +118.63K | — | — | 7.5% | 1.59M | 1.71M |
| American Depositary Shares Direct | 6/11/2026 | S · Sale | −756.00 | $261.00 | $197.32K | New position | 756.00 | 0.00 |
| Total | +117.87K | -$197.32K | ||||||
Derivative Transactions1
Share Option (Right to Buy)
Direct
Converts to
Ordinary Shares
229.78K shares
Shares
+229.78K
Strike price
20.81
Held after
229.78K
Exercisable
—
6/11/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Share Option (Right to Buy) Direct | Ordinary Shares229.78K shares | 6/11/2026 | A · Award | +229.78K | 20.81 | — | 229.78K |
Non-Derivative Holdings (Post-Transaction)2
Ordinary Shares
IndirectShares owned601.97K
RMB Shares
IndirectShares owned0.00
Total
601.97K indirect601.97K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 601.97K | Indirect |
| RMB Shares | 0.00 | Indirect |
| Total | 601.97K | 601.97K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported